Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Biological determinants of health disparities in prostate cancer.

Martin DN, Starks AM, Ambs S.

Curr Opin Oncol. 2013 May;25(3):235-41. doi: 10.1097/CCO.0b013e32835eb5d1. Review.

PMID:
23399519
2.

Tumor immunobiological differences in prostate cancer between African-American and European-American men.

Wallace TA, Prueitt RL, Yi M, Howe TM, Gillespie JW, Yfantis HG, Stephens RM, Caporaso NE, Loffredo CA, Ambs S.

Cancer Res. 2008 Feb 1;68(3):927-36. doi: 10.1158/0008-5472.CAN-07-2608.

3.

Genetic ancestry, self-reported race and ethnicity in African Americans and European Americans in the PCaP cohort.

Sucheston LE, Bensen JT, Xu Z, Singh PK, Preus L, Mohler JL, Su LJ, Fontham ET, Ruiz B, Smith GJ, Taylor JA.

PLoS One. 2012;7(3):e30950. doi: 10.1371/journal.pone.0030950. Epub 2012 Mar 27.

4.

Prostate cancer and African-American men.

Powell IJ.

Oncology (Williston Park). 1997 May;11(5):599-605; discussion 606-15 passim. Review.

5.

Prostate cancer in the African American: is this a different disease?

Powell IJ.

Semin Urol Oncol. 1998 Nov;16(4):221-6. Review.

PMID:
9858329
6.

Racial differences in prostate cancer growth: apoptosis and cell proliferation in Caucasian and African-American patients.

Guo Y, Sigman DB, Borkowski A, Kyprianou N.

Prostate. 2000 Feb 1;42(2):130-6.

PMID:
10617870
8.

Generalizability of established prostate cancer risk variants in men of African ancestry.

Han Y, Signorello LB, Strom SS, Kittles RA, Rybicki BA, Stanford JL, Goodman PJ, Berndt SI, Carpten J, Casey G, Chu L, Conti DV, Rand KA, Diver WR, Hennis AJ, John EM, Kibel AS, Klein EA, Kolb S, Le Marchand L, Leske MC, Murphy AB, Neslund-Dudas C, Park JY, Pettaway C, Rebbeck TR, Gapstur SM, Zheng SL, Wu SY, Witte JS, Xu J, Isaacs W, Ingles SA, Hsing A; PRACTICAL Consortium; ELLIPSE GAME-ON Consortium, Easton DF, Eeles RA, Schumacher FR, Chanock S, Nemesure B, Blot WJ, Stram DO, Henderson BE, Haiman CA.

Int J Cancer. 2015 Mar 1;136(5):1210-7. doi: 10.1002/ijc.29066. Epub 2014 Jul 15.

9.

Lifestyle determinants of 5alpha-reductase metabolites in older African-American, white, and Asian-American men.

Wu AH, Whittemore AS, Kolonel LN, Stanczyk FZ, John EM, Gallagher RP, West DW.

Cancer Epidemiol Biomarkers Prev. 2001 May;10(5):533-8.

10.

Prostate cancer disparities in South Carolina: early detection, special programs, and descriptive epidemiology.

Drake BF, Keane TE, Mosley CM, Adams SA, Elder KT, Modayil MV, Ureda JR, Hebert JR.

J S C Med Assoc. 2006 Aug;102(7):241-9. Review.

PMID:
17319238
11.

Hypermethylation of GSTP1, CD44, and E-cadherin genes in prostate cancer among US Blacks and Whites.

Woodson K, Hayes R, Wideroff L, Villaruz L, Tangrea J.

Prostate. 2003 May 15;55(3):199-205.

PMID:
12692786
12.

Serum androgens and sex hormone-binding globulins in relation to lifestyle factors in older African-American, white, and Asian men in the United States and Canada.

Wu AH, Whittemore AS, Kolonel LN, John EM, Gallagher RP, West DW, Hankin J, Teh CZ, Dreon DM, Paffenbarger RS Jr.

Cancer Epidemiol Biomarkers Prev. 1995 Oct-Nov;4(7):735-41.

13.

Association between a CYP3A4 genetic variant and clinical presentation in African-American prostate cancer patients.

Paris PL, Kupelian PA, Hall JM, Williams TL, Levin H, Klein EA, Casey G, Witte JS.

Cancer Epidemiol Biomarkers Prev. 1999 Oct;8(10):901-5.

14.

Identification of genetic risk associated with prostate cancer using ancestry informative markers.

Ricks-Santi LJ, Apprey V, Mason T, Wilson B, Abbas M, Hernandez W, Hooker S, Doura M, Bonney G, Dunston G, Kittles R, Ahaghotu C.

Prostate Cancer Prostatic Dis. 2012 Dec;15(4):359-64. doi: 10.1038/pcan.2012.19. Epub 2012 Jul 17.

15.

Racial variation in insulin-like growth factor-1 and binding protein-3 concentrations in middle-aged men.

Platz EA, Pollak MN, Rimm EB, Majeed N, Tao Y, Willett WC, Giovannucci E.

Cancer Epidemiol Biomarkers Prev. 1999 Dec;8(12):1107-10.

16.
17.

Prostate-specific antigen levels are higher in African-American than in white patients in a multicenter registration study: results of RTOG 94-12.

Vijayakumar S, Winter K, Sause W, Gallagher MJ, Michalski J, Roach M, Porter A, Bondy M.

Int J Radiat Oncol Biol Phys. 1998 Jan 1;40(1):17-25.

PMID:
9422553
18.

Association of susceptibility alleles in ELAC2/HPC2, RNASEL/HPC1, and MSR1 with prostate cancer severity in European American and African American men.

Rennert H, Zeigler-Johnson CM, Addya K, Finley MJ, Walker AH, Spangler E, Leonard DG, Wein A, Malkowicz SB, Rebbeck TR.

Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):949-57.

19.

Pathology of premalignant lesions and carcinoma of the prostate in African-American men.

Sakr WA, Grignon DJ, Haas GP.

Semin Urol Oncol. 1998 Nov;16(4):214-20. Review.

PMID:
9858328
20.

Early detection issues of prostate cancer in African American men.

Powell IJ.

In Vivo. 1994 May-Jun;8(3):451-2.

PMID:
7803733

Supplemental Content

Support Center